论文信息 - 174 Intensive chemotherapy (idarubicin, ARA-C, VP-16) combined with G-CSF-priming yields high remission rates in patients with advanced MDS and high-risk AML - 字舞流文

174 Intensive chemotherapy (idarubicin, ARA-C, VP-16) combined with G-CSF-priming yields high remission rates in patients with advanced MDS and high-risk AML

A. Ganser | F. Herrmann | W. Hofmann | C. Huber | K. Höffken | G. Heil | O. Ottmann | B. Hertenstein | H. Schmoll | A. Knuth | D. Hoelzer | W. Heit | G. Geissler | K. Hoffmann | T. Buechele | K. Kolbe | W. Langer | J. Fischer | U. Kiehntopf